Chodera, John
Lee, Alpha A.
London, Nir
von Delft, Frank
Article History
First Online: 18 June 2020
Competing interests
: J.D.C is a current member of the Scientific Advisory Board of OpenEye Scientific Software and a scientific consultant for Foresite Labs. The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, Bayer, XtalPi, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, and the Sloan Kettering Institute. A complete funding history for the Chodera lab can be found at ExternalRef removed. A.A.L is the chief scientific officer and a shareholder of PostEra Inc. The Lee laboratory at the University of Cambridge receives funding from multiple sources, including Pfizer, AstraZeneca, the Engineering and Physical Sciences Research Council and the Winton Programme for the Physics of Sustainability. N.L. is a member of the scientific advisory board of Trilogy Sciences. FvD is a member of the SGC. The SGC is a charity (no. 1097737) funded by AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/ EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome [grant no. 106169/ZZ14/Z].
Free to read: This content has been made available to all.